Search | Clinical Trials Finder

Conditions: Adenocarcinoma of the Prostate
Interventions: HR-A, HR-B; Radiation
Lead sponsor: University of Florida; Other
Eligibility: 18 Years to 100 Years · Male only
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2029
U.S. locations: 1
States / cities: Jacksonville, Florida

Conditions: Idiopathic Thrombocytopenic Purpura
Interventions: Eltrombopag, Avatrombopag, Standard of care; Drug
Lead sponsor: Eisai Inc.; Industry
Eligibility: 18 Years to 99 Years
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2013
U.S. locations: 1
States / cities: Watertown, South Dakota

Conditions: Adults, Older Adults
Interventions: RLIC, Sham conditioning, Balance training; Behavioral
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 40 Years to 80 Years
Enrollment: 82 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2017
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Neuroblastoma, Ganglioneuroblastoma
Interventions: Proton Beam Radiation Therapy; Radiation
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 6 Months to 25 Years
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2028
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Cesarean Section Complications, Cesarean Wound; Dehiscence, Cesarean Wound Disruption
Interventions: PICO Negative Pressure Wound Therapy, Standard Dressing; Device
Lead sponsor: Northwell Health; Other
Eligibility: 18 Years to 50 Years · Female only
Enrollment: 153 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2022
U.S. locations: 1
States / cities: New Hyde Park, New York

Conditions: Breast Cancer
Interventions: Stereotactic radiotherapy delivered by CyberKnife, stereotactic radiotherapy; Radiation
Lead sponsor: Essentia Health; Other
Eligibility: 60 Years to 60 Years · Female only
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2025
U.S. locations: 1
States / cities: Duluth, Minnesota

Conditions: Gastroparesis Like Symptoms
Interventions: Activated IB-Stim Device, Inactivated IB-Stim Device; Device
Lead sponsor: The Cleveland Clinic; Other
Eligibility: 18 Years to 60 Years
Enrollment: 140 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Skin Laxity
Interventions: Ulthera® System Treatment, Heavy Water; Device · Other
Lead sponsor: Ulthera, Inc; Industry
Eligibility: 30 Years to 65 Years
Enrollment: 2 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2013
U.S. locations: 1
States / cities: Pasadena, California

Conditions: Glioblastoma
Interventions: Avelumab, Hypofractionated radiation therapy (HFRT); Biological · Radiation
Lead sponsor: NYU Langone Health; Other
Eligibility: 18 Years and older
Enrollment: 6 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2019
U.S. locations: 4
States / cities: Los Angeles, California • San Francisco, California • Boston, Massachusetts + 1 more

Conditions: Infertility
Interventions: GnRH iontophoretic transdermal Lutrepatch, clomiphene citrate, placebo clomiphene citrate, placebo GnRH patch; Drug
Lead sponsor: Ferring Pharmaceuticals; Industry
Eligibility: 18 Years to 38 Years · Female only
Enrollment: 350 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2010
U.S. locations: 35
States / cities: Tucson, Arizona • Jonesboro, Arkansas • San Diego, California + 30 more

Conditions: Healthy, Dyspnea
Interventions: Furosemide, Saline; Drug
Lead sponsor: Beth Israel Deaconess Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 24 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011 – 2017
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Obesity, Overweight, Weight Loss, Health Behavior
Interventions: Core behavioral weight loss intervention, Self-monitoring diet, Self-monitoring weight, Self-monitoring steps; Behavioral
Lead sponsor: Stanford University; Other
Eligibility: 18 Years and older
Enrollment: 176 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: Stanford, California

Conditions: Prostate Cancer
Interventions: Radiation Therapy; Radiation
Lead sponsor: University of Michigan Rogel Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 68 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2016
U.S. locations: 2
States / cities: Sacramento, California • Ann Arbor, Michigan

Conditions: Acute Low-back Pain, Chronic Low-back Pain, Pain, Intractable
Interventions: Duotherm VibraCool Back Device, TENS 8-channel unit; Device
Lead sponsor: MMJ Labs LLC; Industry
Eligibility: 18 Years to 90 Years
Enrollment: 160 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2025
U.S. locations: 2
States / cities: Landover, Maryland • Fairfax, Virginia

Conditions: Tobacco Use Cessation
Interventions: VergeRx, SmokefreeTXT, NRT Lozenge (Combination), Extended NRT Patch (16 weeks), Standard NRT Patch (8 weeks); Behavioral · Drug
Lead sponsor: University of Virginia; Other
Eligibility: 18 Years and older
Enrollment: 592 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2027 – 2032
U.S. locations: 1
States / cities: Charlottesville, Virginia

Conditions: Smoking Cessation
Interventions: Self-help materials, nicotine patch, Smartphone-delivered automated treatment, Counseling; Behavioral · Drug · Other
Lead sponsor: University of Oklahoma; Other
Eligibility: 18 Years to 99 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017
U.S. locations: 1
States / cities: Oklahoma City, Oklahoma

Conditions: Breastfeeding, Dietary Intervention, Milk Expression, Breast
Interventions: Lactation Support and ABME, Lactation Support and meal plan, Lactation Support; Other
Lead sponsor: Arkansas Children's Hospital Research Institute; Other
Eligibility: 18 Years and older · Female only
Enrollment: 240 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2029
U.S. locations: 1
States / cities: Little Rock, Arkansas

Conditions: Diabetes
Interventions: Waitlist, Medically tailored meals - Daily delivery with human interaction, Medically tailored meals - Weekly delivery with no human interaction, Medically tailored meals - Standard MOWCTX delivery with human interaction; Behavioral
Lead sponsor: University of Texas at Austin; Other
Eligibility: 55 Years to 90 Years
Enrollment: 320 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2026
U.S. locations: 2
States / cities: Austin, Texas

Conditions: Anxiety
Interventions: CES treatment using Alpha-Stim technology, Shame CES Treatment; Device
Lead sponsor: Wyndhurst Counseling Center; Other
Eligibility: 18 Years to 65 Years
Enrollment: 115 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012
U.S. locations: 2
States / cities: Lynchburg, Virginia

Conditions: Neoplasm Metastasis, Central Nervous System Metastases
Interventions: Intensity Modulated Radiotherapy; Radiation
Lead sponsor: New Mexico Cancer Research Alliance; Other
Eligibility: 18 Years and older
Enrollment: 29 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2022
U.S. locations: 1
States / cities: Albuquerque, New Mexico

Conditions: Pulmonary Disease, Chronic Obstructive
Interventions: Placebo, tiotropium + Olodaterol, Tiotropium, Olodaterol, Respimat; Drug · Device
Lead sponsor: Boehringer Ingelheim; Industry
Eligibility: 40 Years to 75 Years
Enrollment: 291 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2013
U.S. locations: 11
States / cities: Phoenix, Arizona • Austell, Georgia • Baltimore, Maryland + 8 more

Conditions: Chronic Inflammatory Demyelinating Polyneuropathy
Interventions: Non-invasive vagus nerve stimulation (nVNS), Standard of care treatment; Device · Other
Lead sponsor: Emory University; Other
Eligibility: 5 Years to 21 Years
Enrollment: 2 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022
U.S. locations: 1
States / cities: Atlanta, Georgia

Conditions: Pancreatic Neoplasms, Pancreatic Adenocarcinoma
Interventions: Hyperthermic intraperitoneal chemotherapy, Open pancreaticoduodenectomy, Gemcitabine; Procedure · Drug
Lead sponsor: Wake Forest University Health Sciences; Other
Eligibility: 18 Years to 75 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016
U.S. locations: 1
States / cities: Charlotte, North Carolina

Conditions: Endometrial Cancer, Stage III Endometrial Cancer, Stage III Endometrial Carcinoma, Endometrial Carcinoma, Endometrial Carcinoma Stage III
Interventions: Intensity-modulated radiation therapy, Carboplatin, Paclitaxel; Radiation · Drug
Lead sponsor: Memorial Sloan Kettering Cancer Center; Other
Eligibility: 18 Years and older · Female only
Enrollment: 28 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2027
U.S. locations: 7
States / cities: Basking Ridge, New Jersey • Middletown, New Jersey • Montvale, New Jersey + 4 more

Search by objective public record fields.

Dose-Escalated Proton Radiation Therapy for High-Risk Prostate Cancer

A Phase 3, Multicenter, Randomized, Double-blind,Active-controlled, Parallel-group Trial With an Open-labelExtension Phase to Evaluate the Efficacy and Safety of OralE5501 Versus Eltrombopag, in Adults With Chronic ImmuneThrombocytopenia (Idiopathic Thrombocytopenic Purpura)

Effects of RLIC on Motor Learning in Middle-aged and Older Adults

Phase II Study of Proton Radiation Therapy for Neuroblastoma

PICO Negative Pressure Wound Therapy in Obese Women Undergoing Elective Cesarean Delivery.

Conformal Partial Breast Irradiation With CyberKnife After Resection for Early Stage Breast Cancer

Neuromodulation With Percutaneous Electrical Nerve Field Stimulation

Feasibility Study: Heavy Water Tissue Labeling Protocol

Avelumab With Hypofractionated Radiation Therapy in Adults With Isocitrate Dehydrogenase (IDH) Mutant Glioblastoma

Study to Assess the Efficacy and Safety of Three Dosage Strengths of Pulsatile GnRH Delivered From a Iontophoretic Patch Compared to Oral Treatment With Clomiphene or Placebo in Infertile Females

Aerosol Inhalation Treatment for Dyspnea

Spark: Finding the Optimal Tracking Strategy for Weight Loss in a Digital Health Intervention

Hypofractionated Stereotactic Body Radiation Therapy (SBRT)

Impact of DuoTherm Compared to TENS on Pain and Disability With Acute and Chronic Low Back Pain

VergeRx for Smokers Not Ready to Quit

Smartphone-delivered Automated Video-assisted Smoking Treatment for Patrons of a Food Resource Center

Effect of Prenatal and Postnatal Intervention Strategies on Breastfeeding Outcomes in Women With Excessive Weight (Ready, Set, Nourish Study)

Meals for Me: Drop Shipment Versus Personally-delivered Meals for Diabetes Management

Use of Alpha-Stim Cranial-electrotherapy Stimulation (CES) in the Treatment of Anxiety

Whole Brain Radiation Using IMRT for Patients With Brain Metastases

Effect on Exercise Endurance and Lung Hyperinflation of Tiotropium + Olodaterol in COPD Patients.

Non-invasive Vagus Nerve Stimulation (nVNS) in Pediatric Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

HIPEC as Neoadjuvant Treatment for Resectable Pancreatic Adenocarcinoma

A Study of Short-Course Radiation Therapy With Chemotherapy in People With Endometrial Cancer